Cypress Capital Group Quest Diagnostics Inc Transaction History

Cypress Capital Group

$879 Million
Q3 2024

A detailed history of Cypress Capital Group transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Cypress Capital Group holds 3,756 shares of DGX stock, worth $514,910. This represents 0.06% of its overall portfolio holdings.

Number of Shares

3,756

Previous 3,834 2.03%

Holding current value

$514,910

Previous $524,000 1.91%

% of portfolio

0.06%

Previous 0.06%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$137.09 - $137.09 $10,693 - $10,693	-78 Reduced 2.03%	3,756 $514,000
Q2 2024 Jul 25, 2024	BUY	$125.91 - $144.34 $207,499 - $237,872	1,648 Added 75.39%	3,834 $524,000
Q1 2024 May 08, 2024	SELL	$123.78 - $142.11 $199,409 - $228,939	-1,611 Reduced 42.43%	2,186 $290,000
Q3 2023 Nov 02, 2023	SELL	$121.86 - $144.92 $163,292 - $194,192	-1,340 Reduced 26.09%	3,797 $462,000
Q2 2023 Jul 26, 2023	SELL	$130.56 - $146.84 $130 - $146	-1 Reduced 0.02%	5,137 $722,000
Q1 2023 May 04, 2023	SELL	$131.53 - $155.76 $485,082 - $574,442	-3,688 Reduced 41.79%	5,138 $726,000
Q4 2022 Feb 14, 2023	BUY	$123.31 - $157.26 $33,663 - $42,931	273 Added 3.19%	8,826 $1.38 Million
Q3 2022 Nov 04, 2022	BUY	$121.77 - $141.1 $487 - $564	4 Added 0.05%	8,553 $1.05 Million
Q2 2022 Jul 26, 2022	SELL	$127.07 - $145.39 $6,607 - $7,560	-52 Reduced 0.6%	8,549 $1.14 Million
Q1 2022 May 16, 2022	BUY	$129.09 - $164.35 $14,070 - $17,914	109 Added 1.28%	8,601 $1.18 Million
Q4 2021 Feb 15, 2022	SELL	$140.36 - $173.01 $10,948 - $13,494	-78 Reduced 0.91%	8,492 $1.47 Million
Q3 2021 Oct 12, 2021	BUY	$132.95 - $158.0 $631,512 - $750,500	4,750 Added 124.35%	8,570 $1.25 Million
Q2 2021 Jul 13, 2021	SELL	$126.66 - $141.48 $3,673 - $4,102	-29 Reduced 0.75%	3,820 $504,000
Q1 2021 Apr 14, 2021	SELL	$114.63 - $133.34 $295,860 - $344,150	-2,581 Reduced 40.14%	3,849 $494,000
Q4 2020 Jan 12, 2021	SELL	$112.7 - $128.05 $294,259 - $334,338	-2,611 Reduced 28.88%	6,430 $767,000
Q3 2020 Oct 08, 2020	BUY	$107.05 - $130.01 $130,172 - $158,092	1,216 Added 15.54%	9,041 $1.04 Million
Q2 2020 Jul 10, 2020	BUY	$73.34 - $122.61 $264,390 - $442,009	3,605 Added 85.43%	7,825 $892,000
Q1 2020 Apr 08, 2020	BUY	$75.14 - $115.68 $63,869 - $98,328	850 Added 25.22%	4,220 $339,000
Q3 2019 Oct 10, 2019	BUY	$97.85 - $107.42 $8,806 - $9,667	90 Added 2.74%	3,370 $361,000
Q2 2019 Aug 15, 2019	SELL	$85.18 - $101.94 $18,313 - $21,917	-215 Reduced 6.15%	3,280 $334,000
Q1 2019 May 14, 2019	BUY	$80.68 - $89.92 $281,976 - $314,270	3,495 New	3,495 $314,000
Q2 2018 Aug 15, 2018	SELL	$97.35 - $113.14 $199,567 - $231,937	-2,050 Closed	0 $0
Q1 2018 May 21, 2018	BUY	$96.42 - $107.88 $197,661 - $221,154	2,050 New	2,050 $205,000

Others Institutions Holding DGX

# of Institutions

924

Shares Held

95.1M

Call Options Held

361K

Put Options Held

346K

View Full List

About QUEST DIAGNOSTICS INC

Ticker DGX
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 113,887,000
Market Cap $15.6B
Description
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...

More about DGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cypress Capital Group, based on Form 13F filings with the SEC.

News

Stay updated on Cypress Capital Group with notifications on news.

Account

Cypress Capital Group Quest Diagnostics Inc Transaction History